Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
Danyang Liu, Jiachen Liu, Shuang Liang, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 545-545
Open Access | Times Cited: 21

Showing 21 citing articles:

Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations
Qandeel Rafique, Ali Rehman, Muhammad Sher Afghan, et al.
Computers in Biology and Medicine (2023) Vol. 163, pp. 107191-107191
Open Access | Times Cited: 25
Updating the use of nano-biosensors as promising devices for the diagnosis of coronavirus family members: A systematic review
Adriano Aquino, Vânia Margaret Flosi Paschoalin, Letícia Tessaro, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 211, pp. 114608-114608
Open Access | Times Cited: 31
Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Mai Helmy Hassan, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Harnessing network pharmacology in drug discovery: an integrated approach
Chandra P. Joshi, Ashish Baldi, Neeraj Kumar, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 5
Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis
Habib MotieGhader, Esmaeil Safavi, Ali Rezapour, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
AI-powered drug repurposing for developing COVID-19 treatments
Zhichao Liu, Xi Chen, Wendy Carter, et al.
Elsevier eBooks (2022), pp. 144-154
Closed Access | Times Cited: 13
Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities
Yong Xiang, Kenneth Chi-Yin Wong, Hon‐Cheong So
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1514-1514
Open Access | Times Cited: 17
Curcumin as a natural potential drug candidate against important zoonotic viruses and prions: A narrative review
Setareh Azarkar, Masoud Abedi, Ali Sheikh Olya Lavasani, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 3080-3121
Closed Access | Times Cited: 2
Network Pharmacology Study to Elucidate the Key Targets of Underlying Antihistamines against COVID-19
Ki‐Kwang Oh, Md. Adnan, Dong Ha Cho
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 4, pp. 1597-1609
Open Access | Times Cited: 11
Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection
Gwenolé Loas, Pascal Le Corre
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 691-691
Open Access | Times Cited: 13
Anticancer Potential of Green Synthesized Silver Nanoparticles of the Soft Coral Cladiella pachyclados Supported by Network Pharmacology and In Silico Analyses
Hani A. Alhadrami, Heba Alkhatabi, Fahad H. Abduljabbar, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1846-1846
Open Access | Times Cited: 13
The Potential Complementary Role of Using Chinese Herbal Medicine with Western Medicine in Treating COVID-19 Patients: Pharmacology Network Analysis
Yi-Chin Lu, Liang-Wei Tseng, Yu-Chieh Huang, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 794-794
Open Access | Times Cited: 9
Deciphering molecular mechanisms of SARS-CoV-2 pathogenesis and drug repurposing through GRN motifs: a comprehensive systems biology study
Marzieh Sameni, Seyed Amir Mirmotalebisohi, Zeinab Dehghan, et al.
3 Biotech (2023) Vol. 13, Iss. 4
Open Access | Times Cited: 5
Development of the New Sensor Based on Functionalized Carbon Nanomaterials for Promethazine Hydrochloride Determination
Mirela Samardžić, Mateja Peršić, Aleksandar Széchenyi, et al.
Sensors (2023) Vol. 23, Iss. 5, pp. 2641-2641
Open Access | Times Cited: 4
Systems medicine framework for repurposable drug combinations for COVID-19 comorbidities
S. Saranya, L. Thamanna, P. Chellapandi
Medicine in Omics (2024) Vol. 11, pp. 100038-100038
Open Access | Times Cited: 1
Identification of TACSTD2 as novel therapeutic targets for cisplatin-induced acute kidney injury by multi-omics data integration
Zebin Deng, Zheng Dong, Yinhuai Wang, et al.
Human Genetics (2024) Vol. 143, Iss. 9-10, pp. 1061-1080
Closed Access | Times Cited: 1
Transcriptomic approaches in COVID-19: From infection to vaccines
Luiz Gustavo Gardinassi, Camila Oliveira Silva Souza, Davi Vinícius de Lima, et al.
Elsevier eBooks (2023), pp. 125-144
Closed Access | Times Cited: 2
Current approaches in identification of a novel drug targets for drug repurposing
Khushal Khambhati, Vijai Singh
Progress in molecular biology and translational science (2024), pp. 213-220
Closed Access
Drug Repurposing for COVID-19 Therapy: Pipeline, Current Status and Challenges
Rohit Verma, Shivani Raj, Umang Berry, et al.
(2023), pp. 451-478
Closed Access | Times Cited: 1
Polypharmacology in Old Drug Rediscovery: Drug Repurposing
Zhiguo Wang, Baofeng Yang
Springer eBooks (2022), pp. 535-592
Closed Access | Times Cited: 2
Systems biology in COVID-19
George D. Vavougios, Sotirios G. Zarogiannis, Konstantinos I. Gourgoulianis
Elsevier eBooks (2023), pp. 301-320
Closed Access
Page 1

Scroll to top